1. Is there an ideal strategy for achieving blood pressure goals? LM Ruilope, GL Bakris; 2. Should metabolic syndrome patients with 'stage 2' pre-hypertension receive antihypertensive therapy? BM Egan; 3. Presence of proteinuria and antihypertensive therapy selection, N Khosla, P Sarafidis, GL Bakris; 4. Statins: cholesterol, blood pressure and much more, R Ramamurthy, NJ Stone; 5. Do antihypertensive agents influence lipid profiles and lipid therapy? SK Arora, SI McFarlane; 6. How strong is the evidence for a blood pressure goal of less than 130/80mmHg for the high risk patient? A Rashidi, M Rahman; 7. Approaches to cardiovascular risk reduction in patients with cardio-metabolic - renal risk, WA Hsueh, GL Bakris; 8. Should there be any reluctance to initiate combination antihypertensive therapy in patients with blood pressure of 160/100 mm Hg or higher? WJ Elliott; 9. Is pulse pressure a predictor of therapeutic outcome? GM London, ME Safar; 10. Should selection of antihypertensive therapy be focused on other markers for cardiovascular risk besides blood pressure? JM Flack, SA Nasser, SM O'Connor; 11. Can aggressive treatment of blood pressure prevent progression of kidney disease? AE Briglia, MR Weir; 12. Are there consequences for attempting to achieve blood pressure goals in the first week after a stroke? LL Pedelty, PB Gorelick; 13. Renal stenosis, SI McFarlane, MO Salifu, GL Bakris; Abbreviations; General index.
Ask a Question About this Product More... |